TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Renalytix ( (RNLXY) ) is now available.
Renalytix plc announced it will transition back to filing as a foreign private issuer (FPI) with the Securities and Exchange Commission effective January 1, 2025. The company had been filing as a domestic reporting company since July 1, 2023 but determined it qualified as an FPI as of December 31, 2024, adhering to the guidelines set by the Securities Act of 1933.
More about Renalytix
YTD Price Performance: 23.81%
Average Trading Volume: 80,480
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $48.6M
See more insights into RNLXY stock on TipRanks’ Stock Analysis page.